Trial · NCT05157698
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Body Mass Index (BMI) | Baseline to after the 6-month treatment | BMI is calculated using measured height and weight |
| Primary | Change in Body Mass Index (BMI) | From post-treatment (6-months) to the 12-month follow-up | BMI is calculated using measured height and weight |
| Secondary | Change in Total cholesterol | From baseline at study enrollment to after the 6-month treatment | Total cholesterol will be measured by bloodwork. |
| Secondary | Change in Total cholesterol | From post-treatment (6-months) to the 12-month follow-up | Total cholesterol will be measured by bloodwork. |
| Secondary | Change in HbA1C | From baseline at study enrollment to after the 6-month treatment | HbA1C will be measured by bloodwork. HbA1C |
| Secondary | Change in HbA1C | From post-treatment (6-months) to the 12-month follow-up | HbA1C will be measured by bloodwork. HbA1C |
| Secondary | Change in Glucose | From baseline at study enrollment to after the 6-month treatment | Glucose will be measured by bloodwork. |
| Secondary | Change in Glucose | From post-treatment (6-months) to the 12-month follow-up | Glucose will be measured by bloodwork. |
| Secondary | Change in Loss-of-Control Eating Frequency | From baseline interview at study enrollment to after the 6-month treatment | Loss-of-control eating frequency is a continuous variable of loss-of-control eating episodes .during the past 28 days assessed using the Eating Disorder Examination interview |
| Secondary | Change in Loss-of-Control Eating Frequency | From post-treatment (6-months) to the 12-month follow-up | Loss-of-control eating frequency is a continuous variable of loss-of-control eating episodes during the past 28 days assessed using the Eating Disorder Examination interview. |
| Secondary | Change in Eating Disorder Psychopathology | From baseline interview at study enrollment to after the 6-month treatment | Eating-disorder psychopathology is a continuous variable as assessed by the global score of the Eating Disorder Examination/Eating Disorder Examination-Questionnaire. Scores range from 0-6 (0=no eating-disorder psychopathology; 6=severe eating-disorder psychopathology). |
| Secondary | Change in Eating Disorder Psychopathology | From post-treatment (6-months) to the 12-month follow-up | Eating-disorder psychopathology is a continuous variable as assessed by the global score of the Eating Disorder Examination/Eating Disorder Examination-Questionnaire. Scores range from 0-6 (0=no eating-disorder psychopathology; 6=severe eating-disorder psychopathology). |
| Secondary | Change in Food Craving | From baseline interview at study enrollment to after the 6-month treatment | Food craving is a continuous variable of food craving as assessed by the Food Craving Inventory. Scores range from 0-5 (0=no food craving; 5=greatest food craving). |
| Secondary | Change in Food Craving | From post-treatment (6-months) to the 12-month follow-up | Food craving is a continuous variable of food craving as assessed by the Food Craving Inventory. Scores range from 0-5 (0=no food craving; 5=greatest food craving). |
| Secondary | Change in Depressive Symptoms | From baseline interview at study enrollment to after the 6-month treatment | Depressive Symptoms \[ Time Frame: From baseline interview at study enrollment to after the 6-month treatment \] Depressive symptoms is a continuous variable of depressive symptomatology as assessed by the self-report measure, the Patient Health Questionnaire - 9. Total scores range from 0-27 (0=no depressive symptoms, 27=greater depressive symptoms). Depressive symptoms is a continuous variable of depressive symptomatology as assessed by the self-report measure, the Patient Health Questionnaire - 9. Total scores range from 0-27 (0=no depressive symptoms, 27=greater depressive symptoms). |
| Secondary | Change in Depressive Symptoms | From post-treatment (6-months) to the 12-month follow-up | Depressive Symptoms \[ Time Frame: From baseline interview at study enrollment to after the 6-month treatment \] Depressive symptoms is a continuous variable of depressive symptomatology as assessed by the self-report measure, the Patient Health Questionnaire - 9. Total scores range from 0-27 (0=no depressive symptoms, 27=greater depressive symptoms). Depressive symptoms is a continuous variable of depressive symptomatology as assessed by the self-report measure, the Patient Health Questionnaire - 9. Total scores range from 0-27 (0=no depressive symptoms, 27=greater depressive symptoms). |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05157698/registered